Canada
· Delayed Price · Currency is CAD Trulieve Cannabis Statistics
Total Valuation
Trulieve Cannabis has a market cap or net worth of CAD 2.48 billion. The enterprise value is 3.09 billion.
| Market Cap | 2.48B |
| Enterprise Value | 3.09B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Trulieve Cannabis has 187.32 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Shares Outstanding | 187.32M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 18.47% |
| Owned by Institutions (%) | 6.77% |
| Float | 147.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.58 |
| PB Ratio | 1.31 |
| P/FCF Ratio | 4.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.55, with an EV/FCF ratio of 5.93.
| EV / Earnings | -24.02 |
| EV / Sales | 1.94 |
| EV / EBITDA | 6.55 |
| EV / EBIT | 15.22 |
| EV / FCF | 5.93 |
Financial Position
The company has a current ratio of 5.10, with a Debt / Equity ratio of 58.19.
| Current Ratio | 5.10 |
| Quick Ratio | 2.98 |
| Debt / Equity | 58.19 |
| Debt / EBITDA | 2.33 |
| Debt / FCF | 2.11 |
| Interest Coverage | 2.07 |
Financial Efficiency
Return on equity (ROE) is -6.60% and return on invested capital (ROIC) is 4.02%.
| Return on Equity (ROE) | -6.60% |
| Return on Assets (ROA) | 3.27% |
| Return on Capital (ROIC) | 4.02% |
| Revenue Per Employee | 294,829 |
| Profits Per Employee | -23,807 |
| Employee Count | 5,400 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.22 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +162.57% in the last 52 weeks. The beta is 1.39, so Trulieve Cannabis's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | +162.57% |
| 50-Day Moving Average | 13.35 |
| 200-Day Moving Average | 12.39 |
| Relative Strength Index (RSI) | 48.78 |
| Average Volume (20 Days) | 106,050 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Trulieve Cannabis had revenue of CAD 1.59 billion and -128.56 million in losses. Loss per share was -0.68.
| Revenue | 1.59B |
| Gross Profit | 892.70M |
| Operating Income | 202.87M |
| Pretax Income | 124.55M |
| Net Income | -128.56M |
| EBITDA | 429.69M |
| EBIT | 202.87M |
| Loss Per Share | -0.68 |
Balance Sheet
The company has 486.12 million in cash and 1.10 billion in debt, giving a net cash position of -610.02 million or -3.26 per share.
| Cash & Cash Equivalents | 486.12M |
| Total Debt | 1.10B |
| Net Cash | -610.02M |
| Net Cash Per Share | -3.26 |
| Equity (Book Value) | 1.88B |
| Book Value Per Share | 10.09 |
| Working Capital | 694.29M |
Cash Flow
In the last 12 months, operating cash flow was 598.39 million and capital expenditures -77.98 million, giving a free cash flow of 520.41 million.
| Operating Cash Flow | 598.39M |
| Capital Expenditures | -77.98M |
| Free Cash Flow | 520.41M |
| FCF Per Share | 2.78 |
Margins
Gross margin is 56.07%, with operating and profit margins of 12.74% and -8.07%.
| Gross Margin | 56.07% |
| Operating Margin | 12.74% |
| Pretax Margin | 7.82% |
| Profit Margin | -8.07% |
| EBITDA Margin | 26.99% |
| EBIT Margin | 12.74% |
| FCF Margin | 32.69% |
Dividends & Yields
Trulieve Cannabis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.27% |
| Shareholder Yield | -0.27% |
| Earnings Yield | -5.12% |
| FCF Yield | 20.95% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |